CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
18 research outputs found
Fatores associados à qualidade de vida de pacientes com esquizofrenia
Author
Addington D
Alphs LD
+68Â more
Andersen J
Andreasen NC
Awad AG
Bardenstein KK
Barker S
Beck AT
Bengtsson-Tops A
Bengtsson-Tops A
Bergner M
Birchwood M
Birchwood M
Bow-Thomas CC
Bressan RA
Browne S
Burns T
Carpiniello B
Carvalho RJL
Chan S
Coppini RZ
Corrigan PW
Dickerson FB
Doyle M
Duno R
Evandro Silva Freire Coutinho
Evans S
Fazio AF
Fleck MPA
Fleischhacker WW
Franz M
Gaite L
Gur RE
Guy W
Hamilton M
Hansson L
Heinrichs DW
Heinze M
Henderson S
Hofer A
Huppert JD
Jacobsson L
Kaplan HI
Katschnig H
Katschnig H
Kay SR
Larsen EB
Lehman AF
Lehman AF
Lehman AF
Leonardo Araújo de Souza
Lingjaerde O
Mintz AR
Norman RM
Oliver J
Packer S
Phelan M
Pinikahana J
Priebe S
Reine G
Roder-Wanner UU
Rosen A
Rossler W
Roy MA
Ruggeri M
Skantze K
Sturt E
Ustun TB
Voruganti L
Warner R
Publication venue
'FapUNIFESP (SciELO)'
Publication date
Field of study
Full text link
Crossref
Dissecting negative symptoms in schizophrenia: Opportunities for translation into new treatments
Author
Alphs LD
Balleine B
+4Â more
Bleuler E
Ekman P
Kraepelin E
Van Den Bos R
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
Identification and characterization of histamine H4 receptor.
Author
Alphs LD and Anand R
Beer DJ Matloff SM and Rocklin RE
+7Â more
DRUTEL G
HOUGH L B
LIU C
MORSE K L
NGUYEN T
Raible DG Lenahan T, Fayvilevich Y, Kosinski R and Schulman ES
ZHU Y
Publication venue
'Japanese Pharmacological Society'
Publication date
01/01/2001
Field of study
No full text
Crossref
Negative symptoms of schizophrenia: a problem that will not go away
Author
Alphs LD
Andreasen NC
+17Â more
Buckley PF
Carpenter WT
Carpenter WT
Crow TJ
DeLeon J
Fenton WS
Ginsberg DL
Kay SR
Mayerhoff DL
Min SK
Overall J
Peralta V
Rector NA
Stahl SM
Stahl SM
Stahl SM
Tandon R
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Resistance is not futile: treatment-refractory schizophrenia – overview, evaluation and treatment
Author
Alphs LD
Ballester J
+19Â more
Barber S
Barnes T
Behdani F
Breier AF
Emsley R
Fellner C
Galling B
Johnsen E
Justin Faden
Kelly DL
Lal S
Lally J
Lehman AF
Leslie Citrome
Lieberman JA
Lundbeck H
Morosini PL
Ortiz-Orendain J
Tracy DK
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
An open trial of adjunctive sertraline in the treatment of chronic schizophrenia
Author
Alphs LD
American Psychiatric Association.
+20Â more
Andreasen NC
Barnes TRE.
Brenner R
Costall B
DeLisi L
Doogan DP
Duinkerke SJ
Freedman D
Goff DC
Guy W.
Jackman H
Kane J
Marshall BD
Overall JE
Saller CF
Simpson GM
Siris SG
Siris SG
Stahl SM
Statistical Graphics Corporation.
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)
Author
A Koulman
A Smolinska
+27Â more
Alide Berndzen
D Moher
DV Cicchetti
E von Elm
Eva Barth
Fabian Eichelmann
GH Guyatt
Hedwig Zuberer
Jan Wirsching
JS LaKind
JS LaKind
K Aleksandrova
Krasimira Aleksandrova
L Schwingshackl
Laura Malin Harms
LD Alphs
Leen Sarmini
Matthew Schenk
Moses Olalekan
P Whiting
RJ Bosch
S Grassmann
S Sanderson
SB Nimse
Sophie Graßmann
T Matsushita
V Gallo
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study
Author
A Olincy
Ahmed A Othman
+35Â more
CG AhnAllen
CR Bowie
CS Myers
D Kontis
D Umbricht
Deli Wang
E Granholm
ED Levin
G Simpson
George Haig
George M. Haig
J de Leon
JA Lieberman
JG Harris
Jun Zhao
K Posner
K Rickels
KH Nuechterlein
LD Alphs
M Dold
MF Green
N Andersen
O Agid
R Freedman
R Freedman
RC Smith
RS Keefe
RS Keefe
RS Keefe
RS Kern
RW Buchanan
RW Buchanan
S Kay
T Barnes
ZZ Guan
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014
Author
AM Walker
Amanda J. Wheeler
+45Â more
C Polcwiartek
Committee on Safety of Medicines
D Barardis De
D Fairweather
D Fairweather
Dan Siskind
DJ Siskind
F Andersohn
G Hill
G Honigfeld
G Malalagama
G Remington
J Idanpaan-Heikklia
J Layland
J Munro
J Nielsen
J Reinders
J Robertson
J Tiihonen
JG Kilian
JM Alvir
K Beck
K Hodge
K Winckel
Karl Winckel
KJ Ronaldson
KJ Ronaldson
KJ Ronaldson
L Hazell
L Lahdelma
L Orsolini
L Rolfes
LD Alphs
M Hert De
N Holmes
Nargess Saiepour
Nicholas Myles
O Agid
OA Andreassen
R Land
S Devarajan
Samantha A. Hollingworth
SJ Haas
T Forrester
T Wimberley
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
Author
A Laiz
AF Bots
+37Â more
C van Nieuwkoop
D Currow
D McIlroy
D Schwartz
E Bjerre
EJ Topol
G Tosh
HC Sox
I Ford
Institute of Medicine. Learning what works: infrastructure required for comparative effectiveness research
J Ali
J Bleidorn
John P. A. Ioannidis
JP Jarow
K Loudon
KA Getz
KA Luoma
KE Johnson
LB Piller
LD Alphs
LG Hemkens
LG Hemkens
LG Hemkens
M Zwarenstein
MK Campbell
OM Dekkers
P Aveyard
P Nash
Perrine Janiaud
PM Welsing
Rafael Dal-Ré
SB Freedman
TH Rainer
The Dutch TIA Trial Study Group
TP Staa
TS Wildes
Z Haramiova
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
1
2